Matches in SemOpenAlex for { <https://semopenalex.org/work/W4300963487> ?p ?o ?g. }
- W4300963487 abstract "Ketamine has emerged as a promising pharmacotherapy for depression and other mental illnesses, and the intramuscular (IM) administration of ketamine is now offered at many North American outpatient psychiatric clinics. However, a characterization of the outpatient population receiving IM ketamine treatment and an evaluation of the real-world depression, anxiety, and safety outcomes of long-term psychiatric IM ketamine treatment has not been reported. This study aimed to evaluate the clinical characteristics, treatment patterns, clinical outcomes, and adverse events of patients receiving IM ketamine treatment.Patient data from the electronic health records of a private outpatient psychiatric clinic network in the United States were collected and analyzed retrospectively. Adults with any psychiatric diagnosis who received ketamine treatment only by IM administration from January 2018 to June 2021 were included. A total of 452 patients were included in the cohort.Patients receiving IM ketamine treatment had a mean of 2.8 (SD 1.4) psychiatric diagnoses. 420 (93%) patients had a diagnosis of major depressive disorder, 243 (54%) patients had a diagnosis of generalized anxiety disorder, and 126 (28%) patients had a diagnosis of post-traumatic stress disorder. Patients received a median of 4 (range 1-48) IM ketamine treatments. Median depression scores (PHQ-9) improved 38% from 16.0 (IQR 11.3-21.8) at baseline to 10.0 (IQR 6.0-15.0) at last treatment (p < .001). Median anxiety scores (GAD-7) improved 50% from 14.0 (IQR 8.0-17.0) at baseline to 7.0 (IQR 4.3-11.8) at last treatment (p < .001). With maintenance ketamine treatments, average improvements in depression (PHQ-9) and anxiety (GAD-7) scores of at least 4.7 and 4.9 points were maintained for over 7 months. An adverse event occurred during 59 of 2532 treatments (2.3%).IM ketamine is being utilized to treat psychiatric outpatients with multiple mental illnesses not limited to depression. Average depression and anxiety levels significantly improve throughout IM ketamine treatment and do not regress to baseline during patients' maintenance treatment phase. Prospective studies are recommended to confirm the long-term effectiveness and safety of IM ketamine." @default.
- W4300963487 created "2022-10-04" @default.
- W4300963487 creator A5004880640 @default.
- W4300963487 creator A5025825060 @default.
- W4300963487 creator A5047884744 @default.
- W4300963487 creator A5067337006 @default.
- W4300963487 creator A5081129089 @default.
- W4300963487 creator A5082738156 @default.
- W4300963487 date "2022-10-03" @default.
- W4300963487 modified "2023-09-26" @default.
- W4300963487 title "Real-world depression, anxiety and safety outcomes of intramuscular ketamine treatment: a retrospective descriptive cohort study" @default.
- W4300963487 cites W1969644317 @default.
- W4300963487 cites W1975643778 @default.
- W4300963487 cites W2012982950 @default.
- W4300963487 cites W2018267671 @default.
- W4300963487 cites W2023081218 @default.
- W4300963487 cites W2043705607 @default.
- W4300963487 cites W2050075407 @default.
- W4300963487 cites W2059761623 @default.
- W4300963487 cites W2067391748 @default.
- W4300963487 cites W2074887396 @default.
- W4300963487 cites W2086479412 @default.
- W4300963487 cites W2091363925 @default.
- W4300963487 cites W2123090955 @default.
- W4300963487 cites W2123488676 @default.
- W4300963487 cites W2132322340 @default.
- W4300963487 cites W2154766235 @default.
- W4300963487 cites W2157684896 @default.
- W4300963487 cites W2328324756 @default.
- W4300963487 cites W2330587564 @default.
- W4300963487 cites W2599766179 @default.
- W4300963487 cites W2608289281 @default.
- W4300963487 cites W2608506675 @default.
- W4300963487 cites W2741959390 @default.
- W4300963487 cites W2762798648 @default.
- W4300963487 cites W2789464286 @default.
- W4300963487 cites W2808077203 @default.
- W4300963487 cites W2932518772 @default.
- W4300963487 cites W2935676591 @default.
- W4300963487 cites W2973250424 @default.
- W4300963487 cites W2979686202 @default.
- W4300963487 cites W3044972280 @default.
- W4300963487 cites W3093208599 @default.
- W4300963487 cites W3111975240 @default.
- W4300963487 cites W4200066931 @default.
- W4300963487 doi "https://doi.org/10.1186/s12888-022-04268-5" @default.
- W4300963487 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36192794" @default.
- W4300963487 hasPublicationYear "2022" @default.
- W4300963487 type Work @default.
- W4300963487 citedByCount "3" @default.
- W4300963487 countsByYear W43009634872023 @default.
- W4300963487 crossrefType "journal-article" @default.
- W4300963487 hasAuthorship W4300963487A5004880640 @default.
- W4300963487 hasAuthorship W4300963487A5025825060 @default.
- W4300963487 hasAuthorship W4300963487A5047884744 @default.
- W4300963487 hasAuthorship W4300963487A5067337006 @default.
- W4300963487 hasAuthorship W4300963487A5081129089 @default.
- W4300963487 hasAuthorship W4300963487A5082738156 @default.
- W4300963487 hasBestOaLocation W43009634871 @default.
- W4300963487 hasConcept C118552586 @default.
- W4300963487 hasConcept C126322002 @default.
- W4300963487 hasConcept C139719470 @default.
- W4300963487 hasConcept C162324750 @default.
- W4300963487 hasConcept C167135981 @default.
- W4300963487 hasConcept C195910791 @default.
- W4300963487 hasConcept C197934379 @default.
- W4300963487 hasConcept C2776867660 @default.
- W4300963487 hasConcept C2780795376 @default.
- W4300963487 hasConcept C2908647359 @default.
- W4300963487 hasConcept C558461103 @default.
- W4300963487 hasConcept C71924100 @default.
- W4300963487 hasConcept C72563966 @default.
- W4300963487 hasConcept C99454951 @default.
- W4300963487 hasConceptScore W4300963487C118552586 @default.
- W4300963487 hasConceptScore W4300963487C126322002 @default.
- W4300963487 hasConceptScore W4300963487C139719470 @default.
- W4300963487 hasConceptScore W4300963487C162324750 @default.
- W4300963487 hasConceptScore W4300963487C167135981 @default.
- W4300963487 hasConceptScore W4300963487C195910791 @default.
- W4300963487 hasConceptScore W4300963487C197934379 @default.
- W4300963487 hasConceptScore W4300963487C2776867660 @default.
- W4300963487 hasConceptScore W4300963487C2780795376 @default.
- W4300963487 hasConceptScore W4300963487C2908647359 @default.
- W4300963487 hasConceptScore W4300963487C558461103 @default.
- W4300963487 hasConceptScore W4300963487C71924100 @default.
- W4300963487 hasConceptScore W4300963487C72563966 @default.
- W4300963487 hasConceptScore W4300963487C99454951 @default.
- W4300963487 hasIssue "1" @default.
- W4300963487 hasLocation W43009634871 @default.
- W4300963487 hasLocation W43009634872 @default.
- W4300963487 hasLocation W43009634873 @default.
- W4300963487 hasOpenAccess W4300963487 @default.
- W4300963487 hasPrimaryLocation W43009634871 @default.
- W4300963487 hasRelatedWork W1506449882 @default.
- W4300963487 hasRelatedWork W2093334854 @default.
- W4300963487 hasRelatedWork W2378173657 @default.
- W4300963487 hasRelatedWork W2603773853 @default.
- W4300963487 hasRelatedWork W2607119059 @default.
- W4300963487 hasRelatedWork W2999178663 @default.
- W4300963487 hasRelatedWork W3091553245 @default.